The apoAI-CIII-AIV gene cluster

被引:148
作者
Groenendijk, M
Cantor, RM
de Bruin, TWA
Dallinga-Thie, GM
机构
[1] Univ Utrecht, Dept Internal Med G02 228, Med Ctr, NL-3508 GA Utrecht, Netherlands
[2] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA
[3] Univ Hosp Maastricht, Dept Internal Med, Maastricht, Netherlands
关键词
apolipoproteins A-I; A-IV; C-III; polymorphism; familial combined hyperlipidemia;
D O I
10.1016/S0021-9150(01)00539-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The relationship between variations in the apoAI-CIII-AIV gene cluster and plasma lipid traits has been recognized for at least 15 years. Most studies have been focused upon the association between plasma triglycerides and a genetic variation present in the 3' untranslated region of the apoC-III gene (SstI polymorphism). Although not all studies showed similar results, this variant is most consistently found in association with plasma triglycerides. The other most interesting DNA variant is the mutation present in the promoter region of the apo A-I gene at position -75 (Msp-AI polymorphism), which has been associated with differences in plasma apoA-I and HDL-cholesterol levels. In this review, we will discuss the most frequent occurring genetic variants in the apoAI-CIII-AIV gene cluster and their impact on plasma lipid traits and associations with increased risk on developing coronary artery disease. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:1 / 11
页数:11
相关论文
共 151 条
[1]   INTESTINAL EXPRESSION OF HUMAN APOLIPOPROTEIN A-IV IN TRANSGENIC MICE FAILS TO INFLUENCE DIETARY-LIPID ABSORPTION OR FEEDING-BEHAVIOR [J].
AALTOSETALA, K ;
BISGAIER, CL ;
HO, A ;
KIEFT, KA ;
TRABER, MG ;
KAYDEN, HJ ;
RAMAKRISHNAN, R ;
WALSH, A ;
ESSENBURG, AD ;
BRESLOW, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (04) :1776-1786
[2]  
AaltoSetala K, 1996, J LIPID RES, V37, P1802
[3]   MECHANISM OF HYPERTRIGLYCERIDEMIA IN HUMAN APOLIPOPROTEIN-(APO)-CIII TRANSGENIC MICE - DIMINISHED VERY LOW-DENSITY-LIPOPROTEIN FRACTIONAL CATABOLIC RATE ASSOCIATED WITH INCREASED APO-CIII AND REDUCED APO-E ON THE PARTICLES [J].
AALTOSETALA, K ;
FISHER, EA ;
CHEN, XL ;
CHAJEKSHAUL, T ;
HAYEK, T ;
ZECHNER, R ;
WALSH, A ;
RAMAKRISHNAN, R ;
GINSBERG, HN ;
BRESLOW, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (05) :1889-1900
[4]   DNA POLYMORPHISMS OF THE APOLIPOPROTEIN AI CIII AIV GENE-CLUSTER INFLUENCE PLASMA-CHOLESTEROL AND TRIGLYCERIDE LEVELS IN THE MAYANS OF THE YUCATAN PENINSULA, MEXICO [J].
AHN, YI ;
VALDEZ, R ;
REDDY, AP ;
COLE, SA ;
WEISS, KM ;
FERRELL, RE .
HUMAN HEREDITY, 1991, 41 (05) :281-289
[5]   Families with familial combined hyperlipidemia and families enriched for coronary artery disease share genetic determinants for the atherogenic lipoprotein phenotype [J].
Allayee, H ;
Aouizerat, BE ;
Cantor, RM ;
Dallinga-Thie, GM ;
Krauss, RM ;
Lanning, CD ;
Rotter, JI ;
Lusis, AJ ;
de Bruin, TWA .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 63 (02) :577-585
[6]  
ANGOTTI E, 1994, J BIOL CHEM, V269, P17371
[7]   DNA POLYMORPHISM HAPLOTYPES OF THE HUMAN APOLIPOPROTEIN APOA1-APOC3-APOA4 GENE-CLUSTER [J].
ANTONARAKIS, SE ;
OETTGEN, P ;
CHAKRAVARTI, A ;
HALLORAN, SL ;
HUDSON, RR ;
FEISEE, L ;
KARATHANASIS, SK .
HUMAN GENETICS, 1988, 80 (03) :265-273
[8]   Linkage of a candidate gene locus to familial combined hyperlipidemia -: Lecithin:cholesterol acyltransferase on 16q [J].
Aouizerat, BE ;
Allayee, H ;
Cantor, RM ;
Dallinga-Thie, GM ;
Lanning, CD ;
de Bruin, TWA ;
Lusis, AJ ;
Rotter, JI .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (11) :2730-2736
[9]   Postprandial concentrations and distribution of apo C-III in type 2 diabetic patients. Effect of bezafibrate treatment [J].
Attia, N ;
Durlach, V ;
Cambilleau, M ;
Roche, D ;
Girard-Globa, A .
ATHEROSCLEROSIS, 2000, 149 (02) :427-433
[10]   APOLIPOPROTEIN HOMOLOG OF RAT APOLIPOPROTEIN A-IV IN HUMAN-PLASMA - ISOLATION AND PARTIAL CHARACTERIZATION [J].
BEISIEGEL, U ;
UTERMANN, G .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1979, 93 (03) :601-608